Articles tagged "Safety"

2018 American Transplant Congress
Medication Reconciliation in Abdominal Transplantation
S. Todd,¹ J. Perryman,² R. Subramanian,² A. Patel,² M. Hawthorne,² R. Buenvenida,² K. Lee,² W. Allison,² D. Lo,² P. Reshamwala.²
¹Department of Pharmacy, Emory University Hospital, Atlanta, GA; ²Emory Transplant Center, Emory University Hospital, Atlanta, GA.
Medication adherence post transplantation is vital. Upon discharge, abdominal transplant patients receive a medication list from the electronic medical record (EMR) and obtain a medication…
2018 American Transplant Congress
12-Months Evolution of Anti-HLA Antibodies Donor Specific Antibodies after Rescue Switch from CNi-Based Immunosuppressive Regimen to Belatacept in Kidney Allograft Recipients
M. Matignon,¹ C. Dudreuilh,¹ P. Rémy,¹ J-.L. Taupin,² P. Grimbert.¹
¹Nephrology Transplantation, APHP Henri Mondor, Creteil, France; ²Histocompatibility, APHP Saint Louis, Paris, France.
IntroductionAfter kidney transplantation, long-term immunosuppression with calcineurin inhibitors (CNIs) or mTOR inhibitors (mTORi) leads to adverse effects, such as nephrotoxicity and proteinuria. Currently, available data…
2018 American Transplant Congress
Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study
S. Mulgaonkar,¹ J. Pascual,¹ S. Chadban,¹ H. Tedesco,¹ S. Berger,¹ Y. Qazi,¹ C. Legendre,¹ N. Basic-Jukic,¹ P. Bernhardt,² F. Vincenti.¹
¹TRANSFORM Study Group, Livingston; ²Novartis Pharma AG, Basel, Switzerland.
Purpose: Everolimus (EVR)-facilitated calcineurin inhibitor (CNI) reduction regimens help prevent long-term CNI nephrotoxicity in kidney transplant recipients (KTxRs). TRANSFORM (NCT01950819) is the largest study in…
2018 American Transplant Congress
Living Donor Nephrectomy: Is It as Safe as It Can Be? Analysis of Living Donor Deaths in the United States
D. Keith,¹ J. Brown,² K. Andreoni.³
¹Medicine, Sacred Heart Hospital, Pensacola, FL; ²President, Clinical Integration Solutions, LLC, Health Safety Consultancy Company, New York, NY; ³Surgery, University of Florida, Gainesville, FL.
The reported rate of death from living donor nephrectomy is 3 in 10,000 donations. Although this risk is low, the important question is how many…
2018 American Transplant Congress
Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients with a History of Macrolide Antibiotic Allergy
J. Trofe-Clark,^1,2 M. Doshi,³ O. Fadugba,⁴ M. Lim.²
¹Pharmacy Services, Hospital of Univ. of Pennsylvania, Philadelphia, PA; ²Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA; ³Temple Univ. School of Pharmacy, Philadelphia, PA; ⁴Pulmonary Allergy Critical Care Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA.
Background: Tacrolimus (TAC) is considered a drug of choice for maintenance immunosuppression among kidney transplant (KTX) recipients. Because of structural resemblances between macrolide antibiotics (azithromycin,…
2018 American Transplant Congress
Opioid Use Following Ultrasound-Guided Transverse Abdominis Plane Blocks in Living Donor Nephrectomy Patients
E. Henricksen,¹ D. Quan,¹ C. Freise.²
¹Department of Pharmacy, University of California, San Francisco, San Francisco, CA; ²Department of Surgery, University of California, San Francisco, San Francisco, CA.
Purpose: Post-operative pain management is of major concern in living donor nephrectomy patients. Opioids are often used for post-surgical pain, however they are associated with…
2018 American Transplant Congress
Trends in Safety Reporting to UNOS by Event Type
A. Doyle,¹ S. Tlusty,² R. Urban,² M. Marvin,³ E. Hollinger,⁵ D. Marshman,⁴ M. Green.⁵
¹Medicine, University of Virginia, Charlottesville, VA; ²UNOS, Ichmond, VA; ³Surgery, Geisinger, Davville, PA; ⁴LifeLink Foundation, Norcross, GA; ⁵Surgery, University of Pittsbugh, Pittsburgh, PA; ⁶Surgery, Rush Medical Center, Chicago, IL.
The UNOS Operations and Safety Committee is charged with reviewing reported patient safety situations, identifying safety gaps, addressing high frequency and high impact events, and…
2018 American Transplant Congress
Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 1100 Cases at a Single Center
K. Omoto,^1,2 M. Okumi,¹ Y. Kakuta,¹ H. Noguchi,¹ K. Unagami,¹ M. Inui,¹ H. Ishida,¹ K. Tanabe.¹
¹Department of Urology, Tokyo Women's Medical University, Tokyo, Japan; ²Department of Transplant Surgery, Toda Chuo General Hospital, Toda, Japan.
INTRODUCTION: Laparoscopic donor nephrectomy is a standard method of donor nephrectomy. We have tried to establish the technique of pure retroperitoneoscopic live donor nephrectomy (RPLDN)…
2018 American Transplant Congress
Trends in Safety Reporting to UNOS Related to Non-Recovery, Discard, or Delay
A. Doyle,¹ R. Urban,² S. Tlusty,² M. Marvin,³ E. Hollinger,⁴ D. Marshman,⁵ M. Green.⁶
¹Medicine, University of Virginia, Charlottesville, VA; ²UNOS, Richmond, VA; ³Surgery, Geisinger, Danville, PA; ⁴Surgery, Rush Medical Center, Chicago, IL; ⁵LifeLink Foundation, Norcross, GA; ⁶Surgery, University of Pittsburgh, Pittsburgh, PA.
The UNOS Operations and Safety Committee is charged with reviewing reported patient safety situations, identifying safety gaps, addressing high frequency and high impact events, and…
2018 American Transplant Congress
An Initial Experience with the Endowrist Robotic Endostapling Device for Renal Donor Nephrectomy
M. Tan, H. Pollinger.
Piedmont Transplant Institute, Atlanta.
Introduction:Robot assisted donor nephrectomy has been used an advancement to standard laparoscopic techniques. However, limitations in available instrumentation reduce the efficiency of the procedure especially…